`
`Who Are We?
`
`HOME WHO ARE WE?
`
`OUR PRODUCTS
`
`CONTACT US
`
`LATEST NEWS
`
`Operational, Management and Research Staff
`
`What We Offer
`
`Our technology platform focuses on the use
`of novel molecular therapeutics which target
`the immune system to prevent and fight
`prostate cancer. We also have IP covering
`diagnostic kits for the early detection of
`prostate cancer and for the diagnosis of
`breast cancer.
`
`Contact Us
`
`PHIGENIX, Inc. 191 Peachtree Street Suite
`3200 Atlanta, GA 30303 (404) 9461811 Tel
`(404) 9461894 Fax Email:
`info@phigenix.com
`
`Carlton D. Donald, Ph.D.
`
`Founder & President/CEO
`
`Dr. Donald founded PHIGENIX Pharmaceutical and Biomedical Research Company in 2007. He is the
`inventor of the intellectual property around which the company’s technology is based. Dr. Donald has over 20
`years of experience as a cancer biologist and continues to provide his scientific expertise. To date, Dr.
`Donald has approximately 100 patents, pending patents, and applications in the area of oncology, and has
`authored a number of groundbreaking articles on cancer initiation and progression as well as tumor
`immunity.
`
`PHIGENIX Board of Directors
`
`Coming Soon!!!
`
`PHIGENIX Scientific Advisory Board
`
`Coming Soon!!!
`
`Investors
`
`Coming Soon!!!
`
`1. p.mp3 00:45
`
`
`
`Copyright 2011. Phigenix Pharmaceutical Company. All rights reserved.
`
`Home Our Products Who Are We? Contact Us
`
`Latest New s
`
`http://phigenix.com/whoarewe/
`
`1/1
`
`IMMUNOGEN 2198, pg. 1
`Phigenix v. Immunogen
`IPR2014-00676
`
`